The short answer
Reverse-phase HPLC separates peptides by hydrophobicity and reports purity as the target peak's share of total peak area. That figure is only as complete as what the detector sees. Anything not absorbing at the monitored wavelength is invisible to it.
Key facts
- Technique
- Reverse-phase HPLC
- Separates by
- Hydrophobicity
- Typical detection
- UV at 214–220 nm
- Purity expressed as
- Area percent of total
- Blind to
- Anything not absorbing at that wavelength
- Invisible to it
- Salts, residual solvents, water
How the separation works
The column packing is hydrophobic. A sample is loaded in a mostly aqueous mobile phase, where hydrophobic molecules stick to the packing, then an increasing gradient of organic solvent (usually acetonitrile) progressively releases them. More hydrophobic species elute later. Compounds differing slightly in sequence usually differ slightly in hydrophobicity, which is what makes the separation useful.
What the detector actually sees
Most peptide HPLC monitors ultraviolet absorbance around 214 to 220 nm, where the peptide bond itself absorbs. That is deliberate: it detects any peptide regardless of whether it contains aromatic residues, which 280 nm cannot. The trade-off is that many other things absorb there too, including some solvents.
Research material referenced
BPC-157 5mg, third-party HPLC tested
The limitation that matters most
Area-percent purity is a ratio of what the detector sees. Anything that does not absorb at the monitored wavelength contributes nothing to the total and is therefore invisible. It cannot reduce the purity figure no matter how much is present. Inorganic salts, water and some counter-ions fall into this category. A 99% figure describes 99% of the detectable material, not 99% of what is in the vial.
Why the chromatogram matters more than the number
A single number hides the shape of the result. A trace with one sharp peak and a flat baseline is a different result from one with a main peak and several small shoulders summing to the same percentage. Shoulders close to the main peak often indicate deletion sequences or oxidised species, which are the impurities most likely to matter. A purity figure without a chromatogram is an assertion; with one it is a measurement you can check.
What HPLC does not establish
Identity. A pure sample of the wrong compound gives a beautiful chromatogram. Retention time is weak evidence of identity because it depends on the exact column, gradient and instrument, so it is comparable only against a standard run under identical conditions. Mass spectrometry is what confirms identity, and the two analyses answer different questions.
Reading a figure in context
Expected purity depends on the synthesis. A five-residue peptide should be very pure; a thirty-residue one with difficult couplings has more scope for deletion sequences and a lower figure is less alarming. Judging a number without knowing the length and composition of what was made gives it more or less weight than it deserves.
Frequently asked questions
- Does 99% purity mean 99% of the vial is peptide?
- No. It means 99% of what the detector saw. Salts, water and residual solvents that do not absorb at the monitored wavelength are invisible to the measurement.
- Why 214 nm rather than 280 nm?
- The peptide bond absorbs at 214–220 nm, so every peptide is detected. 280 nm relies on aromatic residues, which many peptides lack.
- Can HPLC confirm identity?
- Only weakly. Retention time depends on the exact instrument and method. Mass spectrometry establishes identity.
Extended research context
The Peptide Reference deep dive
Deep dive: what 'peptide' actually means
A peptide is a short chain of amino acids linked by peptide bonds, typically 2–50 residues. Above that boundary the molecule is usually called a protein. Peptides can be endogenous (produced by the body) or synthetic (manufactured by solid-phase peptide synthesis, SPPS). The 'research peptide' category refers specifically to synthetic peptides supplied for laboratory use: not medicines, not supplements.
Why HPLC and mass spec together
HPLC (High-Performance Liquid Chromatography) reports the purity of a batch by measuring what percentage of the sample matches the target peptide's retention time. Mass spectrometry independently confirms the target's molecular weight. Together they answer two different questions: 'is it clean?' and 'is it the right molecule?'. A CoA that reports only one is incomplete.
How to read a Certificate of Analysis
A complete peptide CoA lists: batch number, HPLC purity (area %), mass-spec measured mass vs theoretical, water content (Karl Fischer), acetate/counterion content, appearance, and often endotoxin and residual solvents. Learn to spot the missing fields, as that's usually where quality claims fall apart.
Research applications
- ▸Reference standards for analytical method development
- ▸Comparator peptides in receptor-binding assays
- ▸Stability testing of lyophilised material
- ▸Formulation R&D for topical and aqueous carriers
- ▸Teaching material for peptide chemistry courses
Handling checklist
- ✓Confirm HPLC ≥98% and mass-spec identity on CoA
- ✓Store lyophilised at −20 °C long-term
- ✓Reconstitute with bacteriostatic or sterile water only
- ✓Aliquot to minimise freeze/thaw cycles
- ✓Label vials with date, concentration, and batch
Common research-handling mistakes
Learnt from thousands of researcher orders across our UK labs.
✗ Buying a peptide without a CoA
Fix: Insist on an in-batch HPLC + mass-spec certificate before purchase.
✗ Using DI water for reconstitution
Fix: Use bacteriostatic (0.9% benzyl alcohol) or sterile water only.
✗ Storing lyophilised vials at room temperature long-term
Fix: Freeze at −20 °C; short-term 2–8 °C is acceptable for weeks, not months.
Continue researching
Peer-reviewed guides, comparators and matched reference materials.
Related questions researchers ask
- What is a research peptide?
- How is peptide purity measured?
- Why is HPLC the standard purity assay?
- What information is on a peptide CoA?
- Why are research peptides lyophilised?
Primary sources & clinical trials
Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.
- PubMedStreuli A et al., Improvement of analysis and transferability in peptide purification. J Pept Sci 2026 (PMID 41667417)pubmed.ncbi.nlm.nih.gov
- PubMedHettiarachchi K et al., Characterization and analysis of a synthetic peptide. J Pept Res 2001 (PMID 11168898)pubmed.ncbi.nlm.nih.gov
- PubMedJaradat DMM: Amino Acids 2018 (PMID 29185032)pubmed.ncbi.nlm.nih.gov
- StandardICH Q2(R1) · Validation of Analytical Procedures (HPLC)ich.org
- StandardUSP <1121> · Nomenclature and USP <621> Chromatographyusp.org
- PubMedNail SL et al., Fundamentals of freeze-drying. Pharm Biotechnol 2002 (PMID 12189727)pubmed.ncbi.nlm.nih.gov
- PubMedManning et al., Stability of protein pharmaceuticals. Pharm Res 2010 (PMID 20143256)pubmed.ncbi.nlm.nih.gov
- FDAFDA · Search Guidance Documents. peptide drug product CMC guidancefda.gov
- EMAEMA · Guideline on development & manufacture of synthetic peptidesema.europa.eu
- PubMedNIH PubMed: Peptide purity HPLC method developmentpubmed.ncbi.nlm.nih.gov
- GuidelineGoogle: Creating helpful, reliable, people-first contentdevelopers.google.com
Written and reviewed by
The UK Peptides Editorial Team · Research library, UK Peptides
The editorial team is responsible for supplier selection, batch release decisions and the content published in this research library. Every article here is sourced to primary literature and every product page to a signed third-party certificate. Corrections are made in place and the review date updated.
More Peptide Reference articles
- HPLC and Mass Spectrometry: What Each AnswersHPLC says how much of a sample is the target; mass spectrometry says whether the target is the right compound. Neither substitutes for the other.
- How to Read a Certificate of AnalysisWhat each field on a CoA actually measures, which ones can be checked against each other, and the internal contradictions worth looking for.
- Lyophilisation: Why Peptides Arrive as PowderFreeze-drying removes water by sublimation, taking away the participant in hydrolysis. What the cake tells you and why cold storage still matters.
- Peptide Terminology: The Words That RecurResidue, N-terminus, amidation, analogue, fragment, agonist. The vocabulary that appears across every peptide description, defined precisely.
- Oligopeptide, Polypeptide, ProteinThree terms describing the same kind of molecule at different lengths. Where each is conventionally applied and why none of the boundaries is chemical.
Popular across the research hub
One flagship guide from every other research category.
- Retatrutide ResearchRetatrutide Chemical Identity: What Can Actually Be Verified
- GHK-Cu (Copper Peptide)What Is Actually In a Copper Peptide Serum?
- TB-500 (Thymosin β4 fragment)Angiogenesis: What the Literature Reports
- BPC-157 (Pentadecapeptide)What Is BPC-157? Origin, Sequence and Evidence
- CJC-1295 & IpamorelinWhat Is CJC-1295? The Two Forms and Their Masses
- Bacteriostatic WaterWhy Bacteriostatic Water Is the Default Peptide Diluent
- Research & Regulatory NewsThe Compounded GLP-1 Crackdown
- GLP-1 & Incretin ScienceA p-Value of 0.0035 and an Effect of 0.16
- MOTS-c (Mitochondrial Peptide)The Structural Reasons the Evidence Is Thin
- Semax (ACTH Fragment Peptide)What a Fragment Keeps Decides What It Does
- Selank (Tuftsin Analogue)What an Aversive-Signs Model Measures
- DSIP (Delta Sleep-Inducing Peptide)What Is DSIP? The Nonapeptide Named for an EEG Effect
- KLOW (Blend)What Is KLOW? KPV, GHK-Cu, BPC-157 and TB-500
- GLOW (Blend)What Is GLOW? GHK-Cu, BPC-157 and TB-500
- MT-2 (Melanotan II)The Pharmacology Works. This Compound Was Not Developed.
- IGF-1 LR3What Is IGF-1 LR3? Why It Is a Protein, Not a Peptide
- GlutathioneWhat Is Glutathione? The Bond That Makes It Unusual
- NAD+What Is NAD+? Structure, Role, and Why It Is Not a Peptide
- KPVWhat Is KPV? The Tripeptide From Alpha-MSH